Sign in

CIK 0001595097

  • Non-accelerated filer
  • Smaller reporting company

Corbus Pharmaceuticals Holdings, Inc.

Sign in to watch
Ticker
CRBP
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
464348039
Phone
+1 617-963-0103
Business address
500 RIVER RIDGE DRIVE, NORWOOD, MA, 02062
Former names
SAV Acquisition Corp
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$1,758,438
in 2 filings, $16K under 10b5-1 plans

Net −$1,758,438. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-12-21 Moran Sean F. Chief Financial Officer Exercise or conversion +87,500 $1.40 $123K 437,110
2020-12-21 Moran Sean F. Chief Financial Officer Sale −87,500 $1.75 $153K 349,610
2020-12-21 Moran Sean F. Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −87,500 $1.40 $123K 87,500
2020-12-18 Moran Sean F. Chief Financial Officer Exercise or conversion +53,610 $1.00 $54K 403,220
2020-12-18 Moran Sean F. Chief Financial Officer Sale −53,610 $1.40 $75K 349,610
2020-12-18 Moran Sean F. Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −53,610 $1.00 $54K 53,610
2020-12-16 Moran Sean F. Chief Financial Officer Exercise or conversion +36,923 $0.17 $6K 386,533
2020-12-16 Moran Sean F. Chief Financial Officer Sale −36,923 $1.32 $49K 349,610
2020-12-16 Moran Sean F. Chief Financial Officer Exercise or conversion · Stock Option (Right to Buy) −36,923 $0.17 $6K 36,923
2020-11-11 Cohen Yuval Chief Executive Officer Purchase +4,240 $1.21 $5K 75,330
2020-07-06 Golumbeski George Director Grant or award · Stock Option(right to buy) +81,000 81,000
2020-05-20 Hochman David P Director Grant or award · Stock Option(right to buy) +40,500 40,500
2020-05-20 HOLMER ALAN F Director Grant or award · Stock Option(right to buy) +40,500 40,500
2020-05-20 Jacques Rachelle Suzanne Director Grant or award · Stock Option(right to buy) +40,500 40,500
2020-05-20 Jenkins John Kenneth Director Grant or award · Stock Option(right to buy) +40,500 40,500
2020-05-20 CATLIN AVERY W Director Grant or award · Stock Option(right to buy) +40,500 40,500
2020-05-20 Salzmann Peter Director Grant or award · Stock Option(right to buy) +40,500 40,500
2020-03-17 Millian Craig Stuart Chief Commercial Officer Purchase +2,000 $4.25 $9K 12,000
2020-03-17 Discordia Robert Paul Chief Operating Officer Purchase +2,840 $3.54 $10K 35,490
2020-03-17 White Barbara Chief Medical Officer Purchase +15,606 $3.63 $57K 206,217

Page 12 of 16 · 320 trades